- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Nov 5, 2022
Discovery & Translation
A gene therapy to drive hyperexcitable neurons back to baseline; plus a conditionally active IL-2 and more
BioCentury’s roundup of translational news
BioCentury | Jun 27, 2019
Product Development
Gene therapy’s next frontier lies beyond rare, monogenic diseases
How gene therapy is transitioning from single gene disorders to a modality of general use
BioCentury | May 15, 2019
Translation in Brief
Lentiviral gene therapy could offer relief to refractory epilepsy patients
An epilepsy gene therapy from UCL could offer an alternative to brain surgery
Items per page:
1 - 5 of 5